Recognised as a centre of excellence for ophthalmic research, its researchers, led by director Professor Alan Stitt, will carry out studies of sight-threatening conditions affecting diabetics and the elderly over the next three years. The team, part of the School of Biomedical Sciences, is based in the Royal Victoria Hospital.
The largest grant has come from the New-York based Juvenile Diabetes Research Foundation which has awarded Professor Stitt over £250,000 for research into diabetic retinopathy – a disease that causes about 40 per cent of new adult blindness in the UK.
After 20 years, almost everyone with type 1 diabetes will develop some form of retinopathy.
Sight can be saved by laser therapy if the condition is detected early enough, but the cost of treating just one person is around £237,000. Professor Stitt and his team will investigate the nature of chemical modifications in the retina and their role in the condition. They will study the effects that oxygen deficiency and high blood glucose can have on the build up of glucose residue in blood vessels in the retina.
Professor Stitt has also been awarded two other grants to research into age-related macular degeneration (AMD) – the leading cause of sight loss in people over 50 in the western world.
Around two million people in UK are affected, with numbers set to rise dramatically as our population ages.
Over £170,000 has been granted by the charity Action Medical Research to try to find important information about the molecular and cellular processes that damage the retina, and cause vision loss in AMD.
The charity Fight for Sight has given over £90,000 for the team to understand the role of chemical modifications and the way they interact with a receptor in causing the condition. It is thought that the receptor for AGEs, known as RAGE, may be responsible for inflammation in the retina and, in particular, within cells known as the retinal pigment epithelium (RPE). These interactions could predispose the patient to AMD.
Prof Stitt, who is internationally renowned for his work, said: “We are delighted with these very prestigious awards.
“Queen’s is a centre of excellence for ophthalmic research in the UK, especially in the study of diabetic retinopathy and age-related macular degeneration.
“These grants reflect our international standing and I am convinced that they will make a telling contribution as we seek to understand the underlying causes of major retinal diseases and, importantly, develop new, effective therapeutic interventions”.
More information about the work of the CVS can be found at http://www.qub.ac.uk/research-centres/CentreforVisionSciences
Lisa Mitchell | alfa
Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku
Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.
In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...
A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.
By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
23.02.2018 | Physics and Astronomy
23.02.2018 | Health and Medicine
23.02.2018 | Physics and Astronomy